National Drug Policy in Nigeria
| Autor: | O Ransome Kuti |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
medicine.medical_specialty
Medical sociology Public health law business.industry Health Policy Public health Public Health Environmental and Occupational Health Developing country International health Political science Environmental health medicine Health care reform business Health policy Social policy |
| Zdroj: | Journal of Public Health Policy. 13:367 |
| ISSN: | 0197-5897 |
| DOI: | 10.2307/3342734 |
| Popis: | zT'v g3 HIS article appeared inWHO'sEssentialDrugsMonitor, No. I2, I99I, in the form of an interview with its editor, Daphne A. Fresle. We believe it carries important implications for national drug policy, not only in developing countries, but also for the United States and *vKseeA other industrial nations. Among other provisions, we are particularly impressed by the requirement in the Nigerian law that "When the pharmacists label their drugs the generic name must appear very boldly under the brand name: it should be at least three-quarters the size of the brand name.. . This also applies to television advertising. After the brand name is given, it has to be followed by the words 'brand of' followed by the generic name." |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink